Healthcare Focus Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Minnesota.

Press releases published on November 9, 2026

3 hours ago

PsychPlus and Minnesota Mental Health Clinics Join Forces to Transform Behavioral Healthcare

Indeterminate EIN Presswire

4 hours ago

INDEPENDENTLY PRODUCED 'WE’RE NOT FINE' MAKES THE LEAP FROM MENTAL HEALTH PODCAST TO PRIME VIDEO AND TUBI

Indeterminate EIN Presswire

an hour ago

Tiziana KOL Call Highlights Consistency Between Positive Phase 2a INFORM-MS Topline Results and Longer-Term Clinical Benefits Observed in Expanded Access Program for Patients with Non-Active Secondary Progressive Multiple Sclerosis Treated with…

Indeterminate GlobeNewswire

2 hours ago

SodaPeak Launch 2026 Advanced Soda Peak Gummies for Male Vitality and Energy Supplement New Information For Multi-Ingredient And Benefits.

Indeterminate GlobeNewswire

2 hours ago

Altimmune Presents Positive Late-Breaking Pemvidutide Data at AASLD The Liver Meeting® 2026 in Patients with Alcohol Use Disorder

Indeterminate GlobeNewswire

3 hours ago

Solana Company to Release Third Quarter 2026 Operating Results on November 11, 2026

Indeterminate GlobeNewswire

3 hours ago

U.S. Postal Service Announces Stamp Subjects for 2027

Indeterminate GlobeNewswire

3 hours ago

Zealand Pharma to participate in the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

3 hours ago

Kyverna Therapeutics Announces Publication of Registrational Miv-cel Data in Patients with Stiff Person Syndrome in JAMA Neurology

Indeterminate GlobeNewswire

3 hours ago

Stanford Medicine Sutter Health Cancer Center expands access to advanced cancer care in the East Bay

Indeterminate GlobeNewswire

4 hours ago

Hinge Bio Shares Encouraging Clinical Data for HB2198, a Novel B-Cell Depleting Agent for Treating Autoimmune Disease, at ACR Convergence 2026

Indeterminate GlobeNewswire

4 hours ago

2026 state mental health rankings released by Mental Health America

Indeterminate GlobeNewswire

4 hours ago

TalkingParents Launches Service Appreciation Discount for Military Members and First Responders

Indeterminate GlobeNewswire

4 hours ago

Baylor Genetics to Highlight the Clinical Value of Genomics in Pediatric Care at the 2026 National Society of Genetic Counselors Annual Meeting

Indeterminate GlobeNewswire

4 hours ago

Cullinan Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

4 hours ago

Kraig Labs Ships Spider Silk to Developers Across Global Industries

Indeterminate GlobeNewswire

5 hours ago

Boehringer Ingelheim's survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase III SYNCHRONIZE-CVOT trial alongside significant cardiometabolic benefits

Indeterminate GlobeNewswire

5 hours ago

Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 SYNCHRONIZE-CVOT trial with significant cardiometabolic benefits

Indeterminate GlobeNewswire

5 hours ago

Oncovita Granted Orphan Drug Designation For MVdeltaC in Mesothelioma by the European Commission

Indeterminate GlobeNewswire

5 hours ago

Pelareorep Induces Coordinated Antiviral Immune Responses and Enhanced Antitumor Immunity in Multiple Myeloma Patients

Indeterminate GlobeNewswire